Currently available biologics for T2 asthma
| Drug | Mechanism | Route |
| Omalizumab | Anti-IgE | Subcutaneous |
| Mepolizumab | Anti-IL-5 | Subcutaneous |
| Reslizumab | Anti-IL-5 | Intravenous |
| Benralizumab | Anti-IL-5Rα | Subcutaneous |
| Dupilumab | Anti-IL-4Rα | Subcutaneous |
R: receptor.